Patients treated with vemurafenib as frontline therapy had a trend toward improved survival (hazard ratio = 10 –9 ; 95% confidence interval, 0-NA; P = .1; Figure 1 C) that did not reach statistical significance, possibly because of small sample size.
← all excerpts
Cardiac involvement resolution is frequent and associated with improved outcome in Erdheim-Chester disease.
1
—
—